Chemotherapy combined with antiangiogenic drugs as salvage therapy in advanced melanoma patients progressing on PD-1 immunotherapy

BACKGROUND: This study aimed to evaluate the effect of salvage therapy with nab-paclitaxel (nab-p) or temozolomide (TMZ) combined with antiangiogenic drugs in programmed death 1 (PD-1) inhibitor-resistant patients with unresectable metastatic melanoma. METHODS: We conducted a retrospective review of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuan, Xu, Weiran, Chi, Zhihong, Si, Lu, Sheng, Xinan, Kong, Yan, Zhou, Li, Mao, Lili, Lian, Bin, Tang, Bixia, Yan, Xieqiao, Bai, Xue, Cui, Chuanliang, Guo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689327/
https://www.ncbi.nlm.nih.gov/pubmed/33221685
http://dx.doi.org/10.1016/j.tranon.2020.100949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689327/
https://www.ncbi.nlm.nih.gov/pubmed/33221685
http://dx.doi.org/10.1016/j.tranon.2020.100949

Ejemplares similares